Komori
Zuiko (6279) · RiskDropped

Economic, capital-investment and business-restructuring risks from COVID-19

First written in FY2020. 7 of 17 entries say "Restated". Latest entry: FY2025.

17entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2021-Q1 – FY2021-Q3RestatedFY2022-Q2 – FY2022-Q3RestatedFY2024-Q1 – FY20252020: 420202021: 320212022: 320222023: 420232024: 220242025: 12025
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1257 companies write about · 1269 as a headwind · 6 as a tailwind

The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1283 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025DroppedAnnual report

    「If a natural disaster such as a major earthquake or one associated with climate change, a fire or accident, a man-made disaster such as terrorism, or an infectious disease occurs, the Group’s facilities, information systems and other assets may be affected.」

    References specifically addressing COVID-19 have been removed, and the risks have been reorganized as general business continuity risks including natural disasters, accidents, terrorism and infectious diseases.
  2. FY2025-H1RestatedAnnual report

    「No new business or other risks arose during the current interim consolidated accounting period. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company has reconfirmed that there have been no new developments or significant changes regarding the risks to the economy, capital investment and business restructuring caused by COVID-19.
  3. FY2025-Q1RestatedAnnual report

    「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」

    The company has reconfirmed that there have been no new developments or significant changes regarding the risks to the economy, capital investment and business restructuring caused by COVID-19.
  4. FY2024-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company has reconfirmed that there have been no new developments or significant changes regarding the risks to the economy, capital investment and business restructuring caused by COVID-19.
  5. FY2024-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company has reconfirmed that there have been no new developments or significant changes regarding the risks to the economy, capital investment and business restructuring caused by COVID-19.
  6. FY2024-Q1RestatedAnnual report

    「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」

    The company has reconfirmed that there have been no new developments or significant changes regarding the risks to the economy, capital investment and business restructuring caused by COVID-19.
  7. FY2023MitigatedAnnual report

    「In 2023, while economic normalization from COVID-19 is progressing in Japan and overseas, the global economy is expected to remain unstable because of interest-rate hikes to address rising prices, concerns about the financial system and the prolonged situation in Ukraine.」

    The situation has shifted from one centered on restrictions on economic activity and lockdowns caused by the pandemic to one in which economic normalization is progressing in Japan and overseas, while other destabilizing factors, including interest-rate hikes, financial system concerns and the situation in Ukraine, remain.
  8. FY2023-Q3Shift in the phase of the pandemic’s impactAnnual report

    「During the cumulative period of the third quarter of the current fiscal year (21 February 2022 to 20 November 2022), the business environment remained uncertain, as events with a significant impact on international and financial conditions continued, including the transition to a new phase toward living with COVID-19, the situation in Ukraine, tighter financial conditions overseas, inflationary pressure, the yen's weakest level against the US dollar in 32 years and foreign-exchange intervention by the Bank of Japan.」

    Regarding COVID-19, the company describes a shift from previous disclosures focused on the spread of infection and lockdowns to a new phase of transition toward living with COVID-19. At the same time, it states that the economic outlook remains uncertain.
  9. FY2023-Q2MaterialisedAnnual report

    「Production activities in Japan have been delayed by the prolonged semiconductor shortage, while production activities at consolidated subsidiary Zuiko (Shanghai) Electrical Equipment Co., Ltd. have been significantly delayed by the lockdown accompanying the increase in new COVID-19 cases in Shanghai, China. As a result, the figure was ¥8,813 million, down 21.2% year on year.」

    Regarding risks related to COVID-19, the company states that the Shanghai lockdown caused significant delays in production activities at a consolidated subsidiary, resulting in sales falling 21.2% year on year.
  10. FY2023-Q1WorsenedAnnual report

    「Although socioeconomic activity has resumed and signs of recovery have emerged as the impact of COVID-19 has continued for an extended period, corporate activity remains affected by the rapid depreciation of the yen related to the international situation, rising raw material and crude oil prices, and COVID-19-related developments including lockdowns in major Chinese cities. The outlook therefore remains uncertain.」

    The company states that the impact of the pandemic has continued for an extended period and that lockdowns in major Chinese cities and other factors continue to affect corporate activity. It also notes the resumption of socioeconomic activity and signs of recovery, while uncertainty related to the pandemic persists.
  11. FY2022-Q3RestatedAnnual report

    「In addition, depending on how the COVID-19 pandemic develops, it may affect the Group’s business activities and its ability to secure earnings.」

    The company continues to explicitly identify the potential impact of COVID-19 on business activities and securing earnings.
  12. FY2022-Q2RestatedAnnual report

    「The spread of COVID-19 may affect the group's business activities and its ability to secure earnings, depending on how the situation develops.」

    The company continues to explicitly identify the potential impact of COVID-19 on business activities and securing earnings. It also refers to the recovery of production activities and installation and acceptance inspection activities.
  13. FY2021MitigatedAnnual report

    「Although the business environment is expected to remain uncertain because of concerns including the prolonged impact of COVID-19, the Group will monitor developments in global industry consolidation and seek to enhance corporate value by taking proactive measures.」

    Although concerns about the prolonged course of the pandemic remain, the company clearly states its policy of monitoring developments in industry consolidation and taking proactive measures.
  14. FY2021-Q3MaterialisedAnnual report

    「The Group faced challenges from delays in installing overseas products at customer sites and conducting acceptance inspections, but is recovering its operations, including through the full-scale resumption of production activities in China. Sales activities have also resumed in earnest, and order-taking activities are showing signs of recovery.」

    The company states that delays in installation, acceptance inspections and other work for products destined for overseas markets have continued because of COVID-19. It also notes the resumption of production in China and sales activities, as well as a recovery trend in order-taking activities.
  15. FY2021-Q2MaterialisedAnnual report

    「The spread of COVID-19 may affect the group's business activities and its ability to secure earnings, depending on how the situation develops.」

    The company continues to explicitly identify the potential impact of COVID-19 on business activities and securing earnings, and states that the impact has materialized in the form of increased difficulty in visiting overseas customers, delays in installation and acceptance inspections, and sales falling short of the initial plan for the fiscal year.
  16. FY2021-Q1MaterialisedAnnual report

    「However, the Group faced difficult conditions in both sales and profits because production activities at its overseas subsidiaries were sluggish as a result of the spread of COVID-19.」

    The company states that the slowdown in production activities at overseas subsidiaries caused by COVID-19 actually materialized as difficult conditions for the Group’s sales and profits.
  17. FY2020First statedAnnual report

    「There are concerns that the global spread of COVID-19 could affect the period of the second medium-term management plan. Although we expect the challenging environment to continue, we will seek to secure profits by expanding domestic and overseas sales of mask-making machines, increasing sales in the medical business, anticipating a rebound in the post-COVID market, expanding orders in global markets and building a structure to improve productivity across the Group.」

    The filing newly identifies the potential impact of the global spread of COVID-19 on the second medium-term management plan, while also describing responses including increased sales of mask-making machines and medical products.
Moved together

"Uncertainty surrounding domestic and overseas economic conditions, foreign exchange rates and resource prices" moved the same way as this thread, in the same document, in 3 of its 17 moves.

333★123
  1. ★This thread
  2. 1Uncertainty surrounding domestic and overseas economic conditions, foreign exchange rates and resource prices3×
  3. 2Deteriorating sales environment due to customer investment plan revisions and the normalization of inbound demand3×
  4. 3Risk of an impact on business performance from persistently high steel prices3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Zuiko yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Economic, capital-investment and business-restructuring risks from COVID-19 | ZUIKO CORPORATION (6279) | Komori